Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HBOC Syndrome”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Testing effectiveness (Phase 2)Study completedNCT02978495
What this trial is testing

Neoadjuvant Carboplatin in Triple Negative Breast Cancer

Who this might be right for
BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
Barretos Cancer Hospital 154
Not applicableEnded earlyNCT01103128
What this trial is testing

Validation of a Mouse Model of Pancreatic Carcinogenesis

Who this might be right for
Pancreatic Cancer
Columbia University 450
Not applicableStudy completedNCT00609505
What this trial is testing

Telemedicine vs. Face-to-Face Cancer Genetic Counseling

Who this might be right for
Hereditary Breast and Ovarian Cancer SyndromeLynch Syndrome
Duke University 130
Not applicableActive Not RecruitingNCT04261972
What this trial is testing

Cell-free DNA in Hereditary And High-Risk Malignancies 1

Who this might be right for
Hereditary Cancer Syndrome
University Health Network, Toronto 1,416
Not applicableUnknownNCT03015376
What this trial is testing

Inherited Susceptible Genes Among Epithelial Ovarian Cancer

Who this might be right for
Ovarian Neoplasm EpithelialHereditary Breast and Ovarian Cancer Syndrome
Peking Union Medical College Hospital 1,000
Not applicableActive Not RecruitingNCT03246841
What this trial is testing

Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.

Who this might be right for
Hereditary Breast and Ovarian CancerMutation
UNICANCER 7,274
Not applicableNot Yet RecruitingNCT07542405
What this trial is testing

A Web-Based Program (Kindred) to Improve the Understanding of Genetic Cancer Risk and Cancer Genetic Testing in African American Families

Who this might be right for
BRCA1-Related Hereditary Breast and Ovarian Cancer SyndromeBRCA2-Related Hereditary Breast and Ovarian Cancer SyndromeHereditary Neoplastic Syndrome+1 more
University of Michigan Rogel Cancer Center 150
Not applicableStudy completedNCT04407611
What this trial is testing

Scalable Communication Modalities for Returning Genetic Research Results

Who this might be right for
Hereditary Breast and Ovarian CancerLynch Syndrome
Boston University 926
Not applicableLooking for participantsNCT03124212
What this trial is testing

Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland

Who this might be right for
Hereditary Breast and Ovarian CancerLynch Syndrome
University of Basel 700
Early research (Phase 1)Study completedNCT00892736
What this trial is testing

Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy

Who this might be right for
Basal-Like Breast CarcinomaBRCA1 Mutation CarrierBRCA2 Mutation Carrier+14 more
National Cancer Institute (NCI) 98
Early research (Phase 1)Study completedNCT03304210
What this trial is testing

PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer

Who this might be right for
Peritoneal CarcinomatosisOvarian Cancer Stage IIIBOvarian Cancer Stage IIIC+8 more
University Hospital, Ghent 20
Large-scale testing (Phase 3)Study completedNCT00685256
What this trial is testing

Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age Children

Who this might be right for
Breast CancerHereditary Breast/Ovarian Cancer (brca1, brca2)
Georgetown University 245
Testing effectiveness (Phase 2)Study completedNCT00253539
What this trial is testing

Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer

Who this might be right for
Breast CancerHereditary Breast/Ovarian Cancer (brca1, brca2)
The Cleveland Clinic 3
Not applicableNot Yet RecruitingNCT07764744
What this trial is testing

Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants

Who this might be right for
Ovarian NeoplasmsBRCA 1 Gene MutationBRCA 2 Gene Mutation+2 more
Weill Medical College of Cornell University 70
Not applicableEnded earlyNCT04668521
What this trial is testing

Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection

Who this might be right for
Adnexal MassGermline BRCA1 Gene MutationGermline BRCA2 Gene Mutation+1 more
Aspira Women's Health 215
Not applicableEnrolling By InvitationNCT06914726
What this trial is testing

Patient Centered Clinical Decision Support for Hereditary Cancer Syndromes

Who this might be right for
Hereditary Breast/Ovarian Cancer (brca1, brca2)Lynch SyndromeGenetic Variation+2 more
HealthPartners Institute 2,488
Not applicableStudy completedNCT03510689
What this trial is testing

Genetics and Heart Health After Cancer Therapy

Who this might be right for
Breast CancerHereditary Breast/Ovarian Cancer (brca1, Brca2)Heart Diseases+1 more
Abramson Cancer Center at Penn Medicine 79
Post-approval studies (Phase 4)Study completedNCT02562170
What this trial is testing

Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study

Who this might be right for
Breast CancerHereditary Breast and Ovarian Cancer Syndrome
Medical University of Vienna 50
Not applicableActive Not RecruitingNCT02653105
What this trial is testing

Women at Risk of Breast Cancer and OLFM4

Who this might be right for
Hereditary Breast and Ovarian Cancer Syndrome
Institut Cancerologie de l'Ouest 150
Not applicableStudy completedNCT03511690
What this trial is testing

Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment

Who this might be right for
Hereditary Breast and Ovarian Cancer
Georgetown University 95
Next Page